Funicular Fund LP 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-06-21 4:30 pm Purchase |
2022-06-15 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 215,093 17.910% |
15,320![]() (+7.67%) |
Filing |
2022-05-11 4:56 pm Purchase |
2022-05-09 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 199,773 16.640% |
18,848![]() (+10.42%) |
Filing |
2022-04-14 4:38 pm Purchase |
2022-04-12 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 180,925 15.060% |
18,842![]() (+11.63%) |
Filing |
2022-04-04 5:10 pm Purchase |
2022-03-31 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 162,083 13.500% |
84,163![]() (+108.01%) |
Filing |
2022-03-28 4:20 pm Purchase |
2022-03-18 | 13D | ARCA biopharma, Inc. ABIO |
Funicular Fund LP | 77,920 6.490% |
77,920![]() (New Position) |
Filing |